| Literature DB >> 28773119 |
Fausto Zuleta1, Angel Murciano2, Sergio A Gehrke3, José E Maté-Sánchez de Val4, José L Calvo-Guirado5, Piedad N De Aza6.
Abstract
This study aimed to investigate the processing parameters and biocompatibility of a novel biphaEntities:
Keywords: bioactivity; biocompatibility; bone cement; dicalcium silicate; implant surface
Year: 2017 PMID: 28773119 PMCID: PMC5551801 DOI: 10.3390/ma10070758
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1XRD patterns of (A) synthesized raw powder materials and (B) cement paste after a 24-h setting at 37 ± 2 °C and 100% relative humidity.
Figure 2Setting temperature of the α´L + β-C2Sss paste.
Figure 3SEM images of the α´L + β-C2Sss paste with an liquid to powder ratio (L/P) ratio of 0.4 after setting for (A) 24 h; (B) 7 days and (C) 21 days.
Figure 4Fracture surface SEM images of the α´L + β-C2Sss paste with an L/P ratio of 0.4 after setting for (A) 24 h; (B) 7 days and (C) 21 days.
Figure 5Surface SEM images of the α´L + β-C2Sss paste with an L/P ratio of 0.4 after soaking in simulated body fluid (SBF) for (A) 24 h; (B) 7 days and (C) 21 days.
Figure 6The FTIR spectrum of the α´L + β-C2Sss cement paste after 7 days and 14 days in SBF in the spectral region 400–4000 cm −1. For comparison purposes, we included the FTIR spectra of the α´L + β-C2Sss cement paste after setting for 24 h.
EDS analysis of the cement paste before soaking in SBF and a raw γ-C2S ceramic for comparative purpose.
| wt % | Ca | P | Si | O |
|---|---|---|---|---|
| γ-C2S | 46.54 | - | 16.29 | 37.16 |
| Cement paste | 45.92 | 1.59 | 15.01 | 37.48 |
Figure 7Morphological features of the human adipose stem cells (hASC) cultured on the α´L + β-C2Sss cement paste for (A) 1 day; (B) 3 days and (C) 10 days.
Figure 8Cell viability of hASC on the α´L + β-C2Sss cement paste after culturing for 1, 5, 7, and 10 days (* significant differences p < 0.05).
Figure 9Histologic results of (A,B) the α´L + β-C2Sss cement samples and (C,D) the control group after (A,C) 30 days and (B,D) 60 days of implantation.
Histomorphometric analysis to evaluate the bone-to-implant contact (BIC) for the α´L + β-C2Sss cement implant.
| Days/(%) | Cement Paste Implant | Control | ||
|---|---|---|---|---|
| 30 Days | 60 Days | 30 Days | 60 Days | |
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | |
| BIC | 48.67 ± 0.83 * | 55.86 ± 0.23 * | 0.00 ± 0.00 | 0.00 ± 0.00 |
| New bone ingrowth | 54.96 ± 2.46 * | 65.53 ± 2.86 * | 17.26 ± 2.73 | 26.17 ± 1.75 |
| Defect closure | 42.46 ± 2.48 * | 58.94 ± 2.48 * | 28.46 ± 2.07 | 30.86 ± 1.86 |
| Residual biomaterial | 45.04 ± 1.67 | 35.42 ± 2.08 | 0.00 ± 0.00 | 0.00 ± 0.00 |
| Resorption rate | 45.21 ± 2.64 | 47.31 ± 2.62 | 0.00 ± 0.00 | 0.00 ± 0.00 |
A Wilcoxon test was run to compare means by assuming a significance level of 95% (p < 0.05). Abbreviation: SD, standard deviation (* significant differences p < 0.05).
Figure 10SEM micrographs of the α´L + β-C2Sss cement paste after (A) 30 days and (B) 60 days of implantation showing the cement material (C), interface and new bone (NB). Images show cement degradation and lack of peripheral gaps surrounding cement particles.
Figure 11The EDS analysis of the α´L + β-C2Sss cement paste-bone interface after 30 and 60 days of implantation. The Wilcoxon test was run to compare means by assuming a significance level of 95% (p < 0.05).